Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -28.99%, near the high end of its 5-year range (-269700.00%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-3096.57%
OPERATING MARGIN AVG 5Y
-28.99%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ernexa Therapeutics Inc.
Market Cap
$3.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3096.57%
5Y Avg
-28.99%
Market Cap
$3.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.62M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
Market Cap
$3.58M
Operating Margin
-25.34%
TTM Avg
-25.34%
3Y Avg
-17.96%
5Y Avg
-5.58%
Market Cap
$3.55M
Operating Margin
-2781.69%
TTM Avg
-3688.91%
3Y Avg
-3165.01%
5Y Avg
-3029.85%
Market Cap
$3.49M
Operating Margin
-3.14%
TTM Avg
-81.95%
3Y Avg
-224.77%
5Y Avg
-179.82%
Market Cap
$3.85M
Operating Margin
-774.90%
TTM Avg
-1185.31%
3Y Avg
-1296.90%
5Y Avg
-883.94%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | $3.61M | 0.00% | 0.00% | -3096.57% | -28.99% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.62M | -364.24% | -350.71% | -763.84% | -1461.60% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.58M | -25.34% | -25.34% | -17.96% | -5.58% |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | -2781.69% | -3688.91% | -3165.01% | -3029.85% |
| Moolec Science S.A. (MLEC)vs › | $3.49M | -3.14% | -81.95% | -224.77% | -179.82% |
| Eocene Ltd. (EOCN)vs › | $3.54M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.85M | -774.90% | -1185.31% | -1296.90% | -883.94% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.32M | -23.11% | -1618.34% | -814.04% | -551.20% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -269700.00% |
| 2024-09-30 | -463.86% |
| 2024-06-30 | -10491.49% |
| 2024-03-31 | -12312.77% |
| 2023-12-31 | -33911.76% |
| 2023-09-30 | -10794.12% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
